Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Cash from Discontinued Operations of 9410000.0 for Q1 2026, down 1128.6% year-on-year from 914833.97 in Q1 2025, and down 198.88% on a QoQ basis from 9517000.0 in Q4 2025.

Aurora Cannabis (ACB) Cash from Discontinued Operations (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash from Discontinued Operations for 9 consecutive years, with 9410000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Discontinued Operations fell 1128.6% year-over-year to 9410000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28180088.79 (up 143.83% YoY) and the FY2026 annual result came in at 4112273.44, down 186.32% from the prior year.
  • Cash from Discontinued Operations declined to 9410000.0 in Q1 2026 per ACB's latest filing, from 9517000.0 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for ACB reached as high as 28839000.0 in Q4 2024 and fell as low as 30882000.0 in Q3 2023.
  • A 5-year average of 3547598.9 and a median of 4333234.88 in 2022 frame the typical range for Cash from Discontinued Operations.
  • Annual changes were most pronounced in 2022 — Cash from Discontinued Operations tumbled 1864.71% — and 2024, when it jumped 647.85%.
  • Year by year, Cash from Discontinued Operations stood at 7811997.98 in 2022, then surged by 32.62% to 5264000.0 in 2023, then soared by 647.85% to 28839000.0 in 2024, then tumbled by 67.0% to 9517000.0 in 2025, then sank by 198.88% to 9410000.0 in 2026.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 9410000.0, 9517000.0, and 765911.21 for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 89.46 Bn 87.60 Bn - -
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn -
3 Zoetis 32.62 Bn 30.68 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn -
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.78 Bn 16.47 Bn 800.70 Mn -
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn -
10 Aurora Cannabis 155.22 Mn 69.97 Mn 21.72 Mn -9.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.41 Mn
Mar 31, 2026 -9.41 Mn
Dec 31, 2025 9.52 Mn
Dec 31, 2025 9.52 Mn
Mar 31, 2025 -765,911.21
Mar 31, 2025 -765,911.21
Dec 31, 2024 28.84 Mn
Dec 31, 2024 28.84 Mn
Sep 30, 2024 -24.89 Mn
Sep 30, 2024 -24.89 Mn
Jun 30, 2024 8.38 Mn
Jun 30, 2024 8.38 Mn
Mar 31, 2024 -457,141.74
Mar 31, 2024 -457,141.74
Dec 31, 2023 -5.26 Mn
Dec 31, 2023 -5.26 Mn
Sep 30, 2023 -30.88 Mn
Sep 30, 2023 -30.88 Mn
Dec 31, 2022 -7.81 Mn
Dec 31, 2022 -7.81 Mn